Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

312
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
312
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

563
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cholesterol-dependent cytolysin promotes <i>Streptococcus</i> systemic spread and induces arachidonic acid accumulation-mediated lethality in a murine intraperitoneal infection model.

Infection and immunity·2026
Same author

IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice.

Nature microbiology·2026
Same author

Remodeling of tRNA modification in Trypanosoma cruzi life forms.

PLoS pathogens·2026
Same author

Early-life Wnt4 expressing colon stromal cells orchestrate lifelong mucosal homeostasis via BMP-driven iNKT cell imprinting.

Nature communications·2026
Same author

A pro-carcinogenic bacterial toxin binds claudin-4 to cleave E-cadherin.

Nature·2026
Same author

IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Feb 9, 2026

Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis
04:23

Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis

Published on: August 25, 2023

2.1K

Infant Rabbit Model for Diarrheal Diseases.

Sören Abel1,2,3, Matthew K Waldor1,2,4

  • 1Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts.

Current Protocols in Microbiology
|August 4, 2015
PubMed
Summary

The infant rabbit model accurately mimics human cholera, allowing researchers to study Vibrio cholerae (V. cholerae) infection and test new cholera treatments.

Keywords:
Vibrio choleraeanimal infection modelcholeraenteric diseaseinfant rabbits

More Related Videos

Author Spotlight: Marmoset Research - Scope and Challenges
04:52

Author Spotlight: Marmoset Research - Scope and Challenges

Published on: June 9, 2023

2.7K
Transthoracic Echocardiographic Examination in the Rabbit Model
14:46

Transthoracic Echocardiographic Examination in the Rabbit Model

Published on: June 1, 2019

13.4K

Related Experiment Videos

Last Updated: Feb 9, 2026

Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis
04:23

Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis

Published on: August 25, 2023

2.1K
Author Spotlight: Marmoset Research - Scope and Challenges
04:52

Author Spotlight: Marmoset Research - Scope and Challenges

Published on: June 9, 2023

2.7K
Transthoracic Echocardiographic Examination in the Rabbit Model
14:46

Transthoracic Echocardiographic Examination in the Rabbit Model

Published on: June 1, 2019

13.4K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Animal Models

Background:

  • Cholera, caused by Vibrio cholerae (V. cholerae), is a severe diarrheal disease posing a significant global health risk, particularly in developing countries.
  • Existing non-surgical small animal models for cholera are limited in their ability to fully replicate human disease pathophysiology.

Purpose of the Study:

  • To provide a detailed protocol for utilizing the infant rabbit model of cholera.
  • To highlight the utility of this model for investigating V. cholerae colonization, enterotoxicity, host responses, and therapeutic interventions.

Main Methods:

  • Detailed description of V. cholerae inoculum preparation.
  • Step-by-step protocol for orogastric inoculation of infant rabbits.
  • Procedures for collecting and processing tissue samples post-infection.

Main Results:

  • The infant rabbit model successfully replicates key features of human cholera, including intestinal colonization by V. cholerae and severe diarrhea.
  • This model allows for the study of specific V. cholerae virulence factors and host immune responses during infection.

Conclusions:

  • The infant rabbit model is a valuable tool for understanding cholera pathogenesis.
  • This model serves as a crucial platform for evaluating the efficacy of novel cholera therapeutics.